PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12529294-5	2003	We subsequently investigated the signal transduction pathways involved in ROS generation and demonstrated that fMLP-stimulated ROS production was inhibited by the phosphatidylinositol 3 kinase (PI3K) inhibitor LY294002, but not by the MAPK/ERK kinase (MEK) inhibitor U0126.	U 0126	267-272	formyl peptide receptor 1	Homo sapiens	111-115	
12529294-6	2003	In contrast, ROS production induced by fMLP stimulation of GM-CSF-primed cells was inhibited by LY294002 and U0126.	U 0126	109-114	formyl peptide receptor 1	Homo sapiens	39-43	
11418683-7	2001	Preincubation of eosinophils with U0126 or SB203580 blocked fMLP-enhanced cPLA(2) activity.	U 0126	34-39	formyl peptide receptor 1	Homo sapiens	60-64	
16253958-4	2006	ERK1/2 inhibition by the MEK1/2 antagonist U0126 in neutrophilic HL-60 cells or HEK 293T cells stably expressing fMLP receptors abolished fMLP-mediated PLD activity.	U 0126	43-48	formyl peptide receptor 1	Homo sapiens	113-117	
11091139-4	2000	The fMLP-mediated 5-LO product formation was also sensitive to MEK inhibition by U0126 and to p38 inhibition by SB203580.	U 0126	81-86	formyl peptide receptor 1	Homo sapiens	4-8	
16253958-4	2006	ERK1/2 inhibition by the MEK1/2 antagonist U0126 in neutrophilic HL-60 cells or HEK 293T cells stably expressing fMLP receptors abolished fMLP-mediated PLD activity.	U 0126	43-48	formyl peptide receptor 1	Homo sapiens	138-142